BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 29962814)

  • 1. Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell.
    Gao JP; Xu W; Liu WT; Yan M; Zhu ZG
    World J Gastroenterol; 2018 Jun; 24(24):2567-2581. PubMed ID: 29962814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.
    Sun L; Huang C; Zhu M; Guo S; Gao Q; Wang Q; Chen B; Li R; Zhao Y; Wang M; Chen Z; Shen B; Zhu W
    Theranostics; 2020; 10(26):11950-11962. PubMed ID: 33204322
    [No Abstract]   [Full Text] [Related]  

  • 3. The Significance of Exosomal RNAs in the Development, Diagnosis, and Treatment of Gastric Cancer.
    Zhao G; Zhou A; Li X; Zhu S; Wang Y; Zhang S; Li P
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33430032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes participate in the carcinogenesis and the malignant behavior of gastric cancer.
    Yan Y; Fu G; Ye Y; Ming L
    Scand J Gastroenterol; 2017 May; 52(5):499-504. PubMed ID: 28128667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PMP22 Regulates Self-Renewal and Chemoresistance of Gastric Cancer Cells.
    Cai W; Chen G; Luo Q; Liu J; Guo X; Zhang T; Ma F; Yuan L; Li B; Cai J
    Mol Cancer Ther; 2017 Jun; 16(6):1187-1198. PubMed ID: 28336807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of cancer stem cells by differentiation therapy.
    Arima Y; Nobusue H; Saya H
    Cancer Sci; 2020 Aug; 111(8):2689-2695. PubMed ID: 32462706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1.
    Zhan P; Shu X; Chen M; Sun L; Yu L; Liu J; Sun L; Yang Z; Ran Y
    Life Sci; 2021 Jul; 276():119405. PubMed ID: 33798550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and identification of chemotherapy-enriched sphere-forming cells from a patient with gastric cancer.
    Bagheri V; Memar B; Behzadi R; Aliakbarian M; Jangjoo A; Bahar MM; Talebi S; Gholamin M; Abbaszadegan MR
    J Cell Physiol; 2018 Oct; 233(10):7036-7046. PubMed ID: 29744869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
    Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
    Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of gastric cancer stem cells using the cell surface marker CD44.
    Takaishi S; Okumura T; Tu S; Wang SS; Shibata W; Vigneshwaran R; Gordon SA; Shimada Y; Wang TC
    Stem Cells; 2009 May; 27(5):1006-20. PubMed ID: 19415765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment.
    Li K; Dan Z; Nie YQ
    World J Gastroenterol; 2014 May; 20(18):5420-6. PubMed ID: 24833872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of the Hedgehog Pathway in Chemoresistance of Gastrointestinal Cancers.
    Liang Y; Yang L; Xie J
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATOH1 Can Regulate the Tumorigenicity of Gastric Cancer Cells by Inducing the Differentiation of Cancer Stem Cells.
    Han ME; Baek SJ; Kim SY; Kang CD; Oh SO
    PLoS One; 2015; 10(5):e0126085. PubMed ID: 25950549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cells Antigen-1 Enriches for a Cancer Stem Cell-Like Subpopulation in Mouse Gastric Cancer.
    Park JW; Park JM; Park DM; Kim DY; Kim HK
    Stem Cells; 2016 May; 34(5):1177-87. PubMed ID: 26869189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer stem cells: a novel therapeutic target.
    Singh SR
    Cancer Lett; 2013 Sep; 338(1):110-9. PubMed ID: 23583679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.